CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Planned sale Director sold 95,719 shares at an average $3.50 ($335,133)
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 20,000 shares at $3.10 ($62,000)
- 4 Grant or award Chief Clinical Officer acquired 70,270 shares (grant or award)
- 4 Grant or award Chief Administrative Officer acquired 55,743 shares (grant or award)
- 4 Other disposition Chief Medical Officer disposed of 16,173 shares (other)
- 4 Other disposition Chief Financial Officer disposed of 20,320 shares (other)
- 4 Other disposition Chief Executive Officer disposed of 98,534 shares (other)
- 4 Open-market buy 10% owner bought 27,429 shares at $2.96 ($81,190)
- 4 Open-market buy 10% owner bought 50,000 shares at $3.15 ($157,500)
- 4 Open-market buy 10% owner bought 125,000 shares at $3.11 ($388,750)
- 4 Open-market buy 10% owner bought 25,000 shares at $3.35 ($83,750)
- 3 Insider Initial Statement of Ownership
- 4 Other disposition Chief Executive Officer disposed of 11,834 shares (other)
Page 3 of 28 · 548 filings